Hidden heart risk in cancer survivors: new study seeks early warning signs
NCT ID NCT01671696
Summary
This study aimed to find better ways to detect early, hidden heart damage in people who survived childhood cancer after receiving certain chemotherapy drugs called anthracyclines. Researchers used advanced heart scans (MRI) and blood tests to look for subtle signs of heart problems before symptoms appear. The goal was to gather knowledge to help develop future treatments to prevent heart failure in this at-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
Conditions
Explore the condition pages connected to this study.